Stay updated on BCD-021 Pharmacokinetics, Safety in AMD Clinical Trial
Sign up to get notified when there's something new on the BCD-021 Pharmacokinetics, Safety in AMD Clinical Trial page.

Latest updates to the BCD-021 Pharmacokinetics, Safety in AMD Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe clinical trial page now displays the study record for BCD-021, including its design, eligibility criteria, interventions, outcome measures, and record dates, instead of a forbidden-error page.SummaryDifference40%

- Check17 days agoChange DetectedThe footer revision number changes from v3.7.2 to v3.8.0 while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check24 days agoChange DetectedA notice announces an NIH website terminology transition, stating that “Super Intelligence” will be used in place of “Artificial Intelligence” during the transition.SummaryDifference1%

- Check31 days agoChange DetectedThe footer revision number changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check38 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check52 days agoChange DetectedThe 403 error page is removed and the study detail view is now accessible, restoring the ability to view information about the trial. This improves user access to essential study details and status.SummaryDifference0.5%

Stay in the know with updates to BCD-021 Pharmacokinetics, Safety in AMD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BCD-021 Pharmacokinetics, Safety in AMD Clinical Trial page.